Clinical Conversations in Diabetes Technology - An AACE Guidelines Update, provided by an education grant from Abbott, Medtronic, Dexcom

Saturday, May 14, 2022

2:30 PM – 3:45 PM

Location: Breakout Room 5-Aqua DEF (Level 3)

Speaker(s)

Sandra L. Weber, MD, FACP, FACE
Chief, Division of Endocrinology
Prisma Health System University of South Carolina School of Medicine - Greenville
Greenville, South Carolina, United States

Disclosure: NIH (Self) : Grant/Research Support (Status: Ongoing), Research Grant (Status: Ongoing); Novo Nordisk (Self) : Research Grant (Status: Ongoing)

PDF Slides

ACCESS A COMPLIMENTARY 1 HOUR CME/CE THAT COMPLIMENTS THIS SESSION ANYTIME DURING THE CONFERENCE!
https://pro.aace.com/educational-opportunities/clinical-conversations-diabetes-technology-aace-guidelines-update-online

Learning Objectives:

Review available diabetes technologies to manage patients with diabetes.
Discuss how CGMs, connected pens, insulin pumps and integrated devices can be applied in the shared clinical-decision making process to better manage patients with diabetes.
Select the appropriate diabetes technologies and devices for each patient and incorporate diabetes technologies that are effective in managing patients in special populations.

Participants should be aware of the following financial/non-financial relationships:

Sandra L. Weber, MD, FACP, FACE: NIH (Individual(s) Involved: Self): Grant/Research Support, Research Grant; Novo Nordisk (Individual(s) Involved: Self): Research Grant